Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients

NCT01447485 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Chronic Kidney Disease
Nephrotic Syndrome

Interventions

DRUG: Valsartan (VAL489)

Sponsor

Novartis Pharmaceuticals